Search
User Avatar Login
The Defender
  • Explore The Defender
  • Categories
    • CHD.TV
  • Explore CHD.TV
  • Archive
    • Resources
  • Explore Our Resources
  • CHD Bookstore
  • CHD Films
  • eBooks
    • Community
  • Explore Advocacy
  • Community
  • Advocacy Help
    • Science
  • Explore the Science Section
  • Science Library
  • Vaccines
  • Electromagnetic Radiation
    • Legal Justice
  • Explore Litigation
  • Learn The Law
    • About Us
  • About Children’s Health Defense
  • More from CHD
    • Vax-Unvax: Let The Science Speak Home › Citations

    Afterword

    This is a listing of all citations in this chapter.

    1

    “HRSA Data and Statistics,” HRSA, June 1, 2023.

    2

    “Vaccines,” US Food and Drug Administration, Feb 8. 2023.

    3

    “How Vaccines are Developed and Approved for Use,” Centers for Disease Control and Prevention, Mar. 30, 2023.

    4

    “Development & Approval Process (CBER),” US Food and Drug Administration, May 4, 2023.

    5

    US Food and Drug Administration, Lipitor:Package Insert (New York, NY: Parke-Davis., a division of Pfizer Inc., updated Apr. 2019).

    6

    US Food and Drug Administration, Enbrel: Package Insert (Thousand Oaks, CA: Immunex Corporation, marketed by Pfizer Inc. and Amgen Inc., updated Sep. 2011).

    7

    US Food and Drug Administration, Stelara: Package Insert (Horsham, PA: Janssen Biotech, Inc., Bloomington, IN: Baxter Pharmaceutical Solutions, updated Sep. 2019).

    8

    US Food and Drug Administration, Energix-B: Package Insert (Research Triangle Park, NC: GlaxoSmithKline, 1989).

    9

    US Food and Drug Administration, Recombivax HB:Package Insert (Whitehouse Station, NJ: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., updated Dec. 2018).

    10

    US Food and Drug Administration, Ipol: Package Insert (Swiftwater PA: Sanofi Pasteur Inc., updated May 2022).

    11

    US Food and Drug Administration, PedvaxHIB: Package Insert (West Point, PA: Merck & Co., Inc., 1998).

    12

    US Food and Drug Administration, Hiberix: Package Insert (Research Triangle Park, NC: GlaxoSmithKline, updated Apr. 2018).

    13

    US Food and Drug Administration, ActHIB: Package Insert (Swiftwater PA: Sanofi Pasteur Inc., updated Mar. 2022).

    14

    Ross Lazarus, “Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS),” The Agency for Healthcare Research and Quality (AHRQ), 2010.

    15

    US Congress, House—Energy and Commerce; Ways and Means and Senate—Labor and Human Resources, National Childhood Vaccine Injury Act of 1986, H.R.5546, 99th Cong., Part 1., 1986, H.Rept 99-908.

    16

    “How to Access Data from the Vaccine Safety Datalink,” Centers for Disease Control and Prevention, updated Aug. 31, 2020.

    17

    “15 U.S. Code § 3710c—Distribution of Royalties Received by Federal Agencies,” Cornell Law School, accessed June 23, 2023.

    18

    “Conflicts of Interest in Vaccine Policy Making Majority Staff Report,” US
    House of Representatives: Committee on Government Reform, June 15, 2000.

    19

    “Conflicts of Interest in Vaccine Policy Making Majority Staff Report,” US
    House of Representatives: Committee on Government Reform, June 15, 2000.

    20

    “CDC’s Ethics Program for Special Government Employees on Federal Advisory Committees,” Department of Health and Human Services: Office of Inspector General, Dec. 2009.

    21

    “What is Evidence Based Practice?,” University of Arkansas for Medical Sciences, Nov. 17, 2022.

    22

    “Adverse Effects of Pertussis and Rubella Vaccines: A Report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines,” Institute of Medicine (1991): 7, doi:10.17226/1815.

    23

    Kathleen R. Stratton, Cynthia Johnson Howe, and Richard B. Johnston Jr., “Adverse Events Associated With Childhood Vaccines Other Than Pertussis and Rubella Summary of a Report from the Institute of Medicine,” JAMA 271, no. 20 (1994): 1602–1605, doi:10.1001/jama.1994.03510440062034.

    24

    Kathleen Stratton et al., “Adverse Effects of Vaccines: Evidence and Causality,” National Academies Press (US), (2011): 19, doi: 10.17226/13164.

    25

    “The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies,” National Academies Press (US), Mar. 27, 2013, doi:10.17226/13563.

    26

    Aviva L. Katz et al., “Informed Consent in Decision-Making in Pediatric Practice,” Pediatrics 138, no. 2 (2016): e20161485, doi:10.1542/peds.2016- 1485.

    27

    “Instructions for Use: Vaccine Information Statement,” Centers for Disease Control and Prevention, updated May 12, 2023.

    28

    Ross Lazarus, “Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS),” The Agency for Healthcare Research and Quality (AHRQ), 2010.

    29

    Christina D. Bethell et al., “A National and State Profile of Leading Health Problems and Health Care Quality for US Children: Key Insurance Disparities and Across-State Variations,” Academic Pediatrics 11, no. 3S (2010): S22–S33, doi:10.1016/j.acap.2010.08.011.